Exiqon AS (EXQ) - Product Pipeline Analysis, 2016 Update

Description-

Summary

Exiqon A/S (Exiqon) is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company offers RNA, microRNA and LNA oligos products. Its RNA products comprise isolation, ISH, GapmeRs, qPCR and microarray systems. Exiqon offers LNA oligo products such as LNA oligo shop and LNA design tools. The company also provides RNA sequencing, microRNA PCR services, online RNA sequencing data analysis, RNA isolation, custom pharma and array services. It offers its gene expression analysis products for the life sciences industry and cellular based diagnostic tests for the diagnostics industry. Exiqon is headquartered in Vedbaek, Denmark.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

To Browse a Report Detail with TOC @ http://www.researchmoz.us/exiqon-as-exq-product-pipeline-analysis-2016-update-report.html

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Exiqon AS

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

To Free Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=746089

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Exiqon A/S Company Snapshot 6

Exiqon A/S Company Overview 6

Exiqon A/S Pipeline Products and Clinical Trials Overview 7

Exiqon A/S Pipeline Analysis Overview 9

Key Facts 9

Exiqon A/S - Major Products and Services 10

Exiqon A/S Pipeline Products by Development Stage 11

Exiqon A/S Pipeline Products Overview 13

Colon Cancer Test - Stage III Patient 13

Colon Cancer Test - Stage III Patient Product Overview 13

Colon Cancer Test - Stage IV Patient 14

Colon Cancer Test - Stage IV Patient Product Overview 14

Diagnostic Test - Prostate Cancer Stratification 15

Diagnostic Test - Prostate Cancer Stratification Product Overview 15

Diagnostic Test - T-Cell Lymphoma 16

Diagnostic Test - T-Cell Lymphoma Product Overview 16

Genetic Test - Prostate Cancer 17

Genetic Test - Prostate Cancer Product Overview 17

miRNA Biomarker - Cancer of Unknown Primary 18

miRNA Biomarker - Cancer of Unknown Primary Product Overview 18

miRNA Test - Endometrial Cancer 19

miRNA Test - Endometrial Cancer Product Overview 19

miRNA Test - Lung Cancer 20

miRNA Test - Lung Cancer Product Overview 20

miRNA test-Ovarian 21

miRNA test-Ovarian Product Overview 21

miRNAbiomarker - Breast cancer 22

miRNAbiomarker - Breast cancer Product Overview 22

Prognosis Test - Prostate Cancer 23

Prognosis Test - Prostate Cancer Product Overview 23

Prostate Cancer - Early Detection Test 24

Prostate Cancer - Early Detection Test Product Overview 24

Prostate Cancer - Treatment Selection Test 25

Prostate Cancer - Treatment Selection Test Product Overview 25

Ran Biomarker Diagnostic Test 26

Ran Biomarker Diagnostic Test Product Overview 26

Exiqon A/S - Key Competitors 27

Exiqon A/S - Key Employees 28

Exiqon A/S - Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 30

Exiqon A/S, Recent Developments 30

Apr 26, 2016: Exiqon: First Quarter 2016 Supports Continued Strong Momentum 30

Feb 08, 2016: Exiqon realizes full year 2015 profitability driven by strong revenue growth 30

Nov 06, 2015: Accelerated RNA discovery by XploreRNA presented to audience at Genome Festival 31

Oct 26, 2015: Third consecutive profitable quarter with continued strong growth 31

Aug 25, 2015: Exiqon: Continued strong performance in the second quarter with 24% growth and profitability 32

Jun 30, 2015: Exiqon integrates RNAseq workflow in unique cloud-computing environment, XploreRNA 33

Jun 30, 2015: Exiqon launches ExiLERATE LNA qPCR product portfolio for analysis of mRNA and lncRNA 33

Dec 18, 2014: Exiqon launches new Research Use Only kit for PCR analysis of colon cancer samples 34

Dec 18, 2014: Exiqon launches new Research Use Only kit miRSIGN miR-21 Oncogene assay 34

May 07, 2014: Exiqon Announces Interim Report For The Period 1 January - 31 March 2014 34

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36

List of Tables

Exiqon A/S Pipeline Products and Clinical Trials Overview 7

Exiqon A/S Pipeline Products by Equipment Type 7

Exiqon A/S Pipeline Products by Indication 8

Exiqon A/S, Key Facts 9

Exiqon A/S, Major Products and Services 10

Exiqon A/S Number of Pipeline Products by Development Stage 11

Exiqon A/S Pipeline Products Summary by Development Stage 12

Colon Cancer Test - Stage III Patient - Product Status 13

Colon Cancer Test - Stage III Patient - Product Description 13

Colon Cancer Test - Stage IV Patient - Product Status 14

Colon Cancer Test - Stage IV Patient - Product Description 14

Diagnostic Test - Prostate Cancer Stratification - Product Status 15

Diagnostic Test - Prostate Cancer Stratification - Product Description 15

Diagnostic Test - T-Cell Lymphoma - Product Status 16

Diagnostic Test - T-Cell Lymphoma - Product Description 16

Genetic Test - Prostate Cancer - Product Status 17

Genetic Test - Prostate Cancer - Product Description 17

miRNA Biomarker - Cancer of Unknown Primary - Product Status 18

miRNA Biomarker - Cancer of Unknown Primary - Product Description 18

miRNA Test - Endometrial Cancer - Product Status 19

miRNA Test - Endometrial Cancer - Product Description 19

miRNA Test - Lung Cancer - Product Status 20

miRNA Test - Lung Cancer - Product Description 20

miRNA test-Ovarian - Product Status 21

miRNA test-Ovarian - Product Description 21

miRNAbiomarker - Breast cancer - Product Status 22

miRNAbiomarker - Breast cancer - Product Description 22

Prognosis Test - Prostate Cancer - Product Status 23

To Enquire Regarding This Report @ http://www.researchmoz.us/enquiry.php?type=E&repid=746089

For More Information Kindly Contact:

ResearchMoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States
http://www.researchmoz.us,

866-997-4948 (Us-Canada Toll Free),
+1-518-621-2074,
Email to: sales@researchmoz.us,